Athira Pharma Sued by Two Sets of Stockholders After CEO Placed on Leave

Health
your username
15 hours ago
Athira Pharma, Inc. and its CEO, Leen Kawas, were sued by two groups of stockholder plaintiffs Friday. The first suit, by plaintiffs Fan Wang and Hang Gao, was brought over claims that the company violated federal securities laws and defrauded its investors through misleading statements about the status of the company. 
The plaintiffs have requested class certification for all investors who held stock in Athira between September 2020 and June 17, 2021. The plaintiffs are demanding a trial by jury, and ultimately seeking punitive and compensatory damages, litigation costs, as well as any other relief the court may deem just and proper. The case was filed Friday in the Western District of Washington.

Related Keywords

Washington ,United States ,Washington State University ,Tai Slyne ,Athira Pharma Inc ,Keller Rohrback ,Securities Exchange ,Athira Pharma ,Leen Kawas ,Fan Wang ,Chang Gao ,Western District ,Securities Exchange Act ,Tousley Brain ,வாஷிங்டன் ,ஒன்றுபட்டது மாநிலங்களில் ,வாஷிங்டன் நிலை பல்கலைக்கழகம் ,அதிரா பார்மா இன்க் ,கெல்லரர் ரோஹ்ர்பக்க் ,பத்திரங்கள் பரிமாற்றம் ,அதிரா பார்மா ,லீன் காவச் ,விசிறி வாங் ,செயலிழக்க கொ ,மேற்கு மாவட்டம் ,பத்திரங்கள் பரிமாற்றம் நாடகம் ,தோஊசிலெய் மூளை ,